CAS NO: | 914913-88-5 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
Physical Appearance | A solid |
Storage | Store at -20°C |
M.Wt | 406.43 |
Cas No. | 914913-88-5 |
Formula | C24H22O6 |
Solubility | insoluble in EtOH; insoluble in H2O; ≥41 mg/mL in DMSO with gentle warming |
Chemical Name | 8-(1-hydroxyethyl)-2-methoxy-3-[(4-methoxyphenyl)methoxy]benzo[c]chromen-6-one |
Canonical SMILES | CC(C1=CC2=C(C=C1)C3=CC(=C(C=C3OC2=O)OCC4=CC=C(C=C4)OC)OC)O |
运输条件 | 蓝冰运输或根据您的需求运输。 |
一般建议 | 为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同厂家不同批次产品溶解度各有差异,仅做参考。若实验所需浓度过大至产品溶解极限,请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存,请尽快用完。 |
Palomid 529 (P529)是新型的高效抗肿瘤PI3K/Akt/mTOR抑制剂,在NCI-60细胞系中的GI50值小于35 μM [1].Palomid 529抑制VEGF和bFGF驱动的内皮细胞增殖,IC50值分别为20 nM和30 nM.
PI3K激活AKT,随后AKT激活CREB,抑制胞浆中p27定位FOXO,激活PtdIns-3ps和能高效转录p70或4EBP1的mTOR [2, 3].
PI3K/Akt/mTOR信号通路在多种癌症中过度活化,减少凋亡并促进增殖.与促进成体干细胞的分化相比,该信号通路对促进成体干细胞的生长和增殖是必需的,尤其是神经干细胞.此外,此通路也是神经长程增强中的重要组分[4].在NSCs中,降低PI3K通路的效应,同时提高GSK3β和HB9的效应是使这些细胞更有利于神经元存活的潜在方式.放大的PI3K/AKT通路能提高神经细胞生长,以此能确定bisperoxovanadium刺激轴突生长而不致癌的适宜处理浓度.Palomid 529不仅能够抑制放射诱导的Id-1和VEGF过表达,也能下调放射诱导的MMP-2和MMP-9 [5].
参考文献:
1 Xue Q, et al. “Palomid 529, a novel small-molecule drug, is a TORC1/TORC2 inhibitor that reduces tumor growth, tumor angiogenesis, and vascular permeability.” Cancer Res, 2008, 68(22), 9551-9557.
2 Rafalski, V. A.; Brunet, A. "Energy metabolism in adult neural stem cell fate". Progress in Neurobiology . 2011, 93 (2): 182–203.
3 Ojeda, L. et al. "Critical role of PI3K/Akt/GSK3β in motoneuron specification from human neural stem cells in response to FGF2 and EGF". PLoS ONE 2011, 6 (8): e23414.
4 Sui, L; Wang, J; Li, B. M. "Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortex". Learning & Memory 2008,15 (10): 762–76.
5 Diaz R, et al. “The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer” .Br J Cancer 2009, 100(6), 932-940.
Description | Palomid 529 (P529)是mTORC1和mTORC2的抑制剂. | |||||
靶点 | mTORC1 | mTORC2 | ||||
IC50 |